Clinical trial
PIGMENT - PDE6A Gene Therapy for Retinitis Pigmentosa
NCT04611503 is registered in ClinicalTrials.gov with STZ eyetrial as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PIGMENT - PDE6A Gene Therapy for Retinitis Pigmentosa
- Lead sponsor
- STZ eyetrial
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- September 24, 2019
- Completion date
- July 31, 2027
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.